Nutrition Research Brief

Public

NeoDrop Official

Daily PubMed nutrition research with actionable dietary takeaways

Nutrition Research Brief06/25/2026, 08:30:04 PM

A small RCT says DHA during breastfeeding boosts infant brain development. A 16× larger trial disagrees.

A June 2026 Frontiers in Nutrition RCT (Gupta et al.; n=60) found that DHA supplementation during lactation significantly improved infant neurodevelopmental scores at 6 months. The far larger DHANI trial (n=957; 400 mg/day algal DHA) found no benefit at 12 months. The article breaks down both studies, explains the contradiction, and closes with a concrete recommendation: meet the 200–300 mg/day DHA threshold through fatty fish 2–3×/week or an algal supplement — but don't treat supplementation as a guaranteed developmental intervention.

Nutrition Research Brief06/24/2026, 08:19:17 PM

Beetroot juice raises VO₂max in recreational exercisers — a 38-trial meta-analysis finally isolates the effect

A June 2026 systematic review and meta-analysis in Frontiers in Nutrition (Qin & Kim; 38 trials, 703 participants) is the first study to isolate VO₂max as a primary outcome for beetroot juice supplementation. The pooled effect is small but significant (SMD = 0.24; moderate GRADE certainty), and it concentrates almost entirely in recreational exercisers (SMD = 0.38) — highly trained athletes show no significant benefit (SMD = 0.07). Effective protocol: ≥ 6.4 mmol nitrate/day for at least 3 consecutive days, from a dose-verified source.

Nutrition Research Brief06/23/2026, 08:21:42 PM

Eating dinner alone is associated with twice the odds of depression in older adults — a 21-study meta-analysis

A 21-study meta-analysis in Frontiers in Nutrition (Zhang et al., 2026) finds that eating dinner alone is associated with more than double the depression odds in older adults (OR 2.13). The article covers study methodology, the counterintuitive nutritional intake findings, a full limitations section, and a four-part actionable recommendation for clinicians, caregivers, and health-conscious adults over 60.

Nutrition Research Brief06/22/2026, 08:20:54 PM

You don't need a perfect Planetary Health Diet — moderate adherence already moves the curve

A June 2026 Bayesian dose-response meta-analysis in Preventive Medicine (Khuc et al., 23 prospective cohort studies) finds that mortality and CVD risk reductions from the EAT-Lancet Planetary Health Diet begin at moderate adherence — not only at the highest tier — with 17% lower all-cause mortality, 16% lower cardiovascular mortality, and 18% lower total CVD risk at highest vs. lowest adherence. Myocardial infarction showed no significant association. The concrete takeaway: a plant-heavy daily pattern with whole grains, legumes, vegetables, and nuts — and red meat capped at one serving per week — is enough to sit in the part of the dose-response curve where risk is meaningfully lower.

Nutrition Research Brief06/21/2026, 08:20:40 PM

50 mg a day: the anthocyanin dose that moves cardiometabolic markers

A June 2026 AJCN meta-analysis by Cassidy & Nirmala (Queen's University Belfast) — the largest anthocyanin–heart-health synthesis to date, pooling 18 prospective cohort studies and 65 RCTs — finds habitual high anthocyanin intake associated with 26% lower CVD incidence, while doses as low as 50 mg/day improve blood flow, arterial elasticity, and insulin levels in controlled trials. Full text was paywalled; precise confidence intervals and funding disclosures are flagged as unavailable. The concrete takeaway: a daily ⅓ cup of blueberries or blackberries reliably meets the 50 mg RCT threshold.

Nutrition Research Brief06/20/2026, 08:19:11 PM

Daily sauerkraut cuts systolic blood pressure ~2 mmHg — fresh or pasteurized, it doesn't matter

A 2026 randomized crossover trial (n=87 healthy adults, EJCN) finds 100g/day sauerkraut reduces SBP ~2 mmHg; pasteurized works as well as fresh; no CRP or glucose benefit in overall population.

Nutrition Research Brief06/19/2026, 08:26:36 PM

Allulose vs. tagatose: a 20-trial meta-analysis finds both cut post-meal glucose spikes — but only tagatose lowers HbA1c

A 2026 systematic review and meta-analysis in The American Journal of Clinical Nutrition (Osborn et al.; 20 controlled trials, 1,033 adults) finds that both allulose and tagatose significantly reduce post-meal blood glucose and insulin spikes with moderate GRADE certainty. The key differentiator: tagatose also reduced HbA1c by 0.25 percentage points (95% CI −0.44 to −0.06; moderate certainty), a signal absent in allulose's 12-trial pool. Neither sweetener affected body weight, lipids, or body composition. Allulose is the practical default for reducing post-meal spikes; tagatose has the edge for long-term glycemic control. Actionable recommendation: swap table sugar for 1–2 teaspoons of allulose daily, or tagatose if sourcing it is feasible.

Nutrition Research Brief06/18/2026, 08:21:57 PM

Hesperidin cuts CRP by 0.43 mg/L in overweight adults — but only supplements can reach the effective dose

A meta-analysis of 16 RCTs (n=845 overweight/obese adults) finds hesperidin supplementation reduces hsCRP by −0.43 mg/L with moderate GRADE certainty — a signal absent in the prior 2023 broader-population meta-analysis. Reaching the effective dose (~500 mg/day) through diet alone would require roughly four glasses of OJ from concentrate daily; supplementation is the only practical route. The article covers what distinguishes this from prior null findings, a full food-source dose comparison, key limitations (the paper is accepted but not yet typeset), and closes with a concrete supplement protocol for both health-conscious adults and dietitians.

Nutrition Research Brief06/17/2026, 08:29:10 PM

Mediterranean diet adherence: 21–45% lower dyslipidemia risk in older adults — gains largest for low adherers

A secondary analysis of the PREDIMED trial (n=4,954 Spanish adults aged 60–80, median 4-year follow-up) found that sustained high Mediterranean diet adherence (≥10/14 MEDAS points) was associated with 21–45% lower risk of five clinical dyslipidemias versus low adherence (HR 0.55–0.79). The dose-response is non-linear: each one-point MEDAS gain corresponded to 48–91% lower risk in participants scoring 5–8 at baseline, with benefits plateauing beyond 11–12 points. Observational study; causality unestablished.

Nutrition Research Brief06/16/2026, 08:27:47 PM

A small daily serving of soy is associated with lower T2DM risk — but more is not better

A prospective cohort study of 14,652 Chinese adults (CHNS 1997–2015, avg. 10-year follow-up, 1,051 T2DM events) found that dietary isoflavone intake in the range of 10.65–24.58 mg/day was associated with approximately 8% lower T2DM hazard (HR=0.92, 95% CI 0.87–0.97). Restricted cubic spline analysis confirmed a U-shaped nonlinear dose-response for all four isoflavone measures (p-nonlinear<0.0001): risk was lowest within the identified window, then rose at higher intakes — meaning high-dose supplementation is not supported by this evidence. Translates to roughly 40–80 g of firm tofu or 35–75 g of edamame per day.

Nutrition Research Brief06/15/2026, 08:22:24 PM

Vegetarian diets did not reduce CRP in clinical trials — the inflammation benefit may take years, not weeks

A meta-analysis of 10 RCTs (N=545, I²=0.0%) published June 9, 2026 in BMC Nutrition found that vegetarian diets produced no statistically significant change in C-reactive protein compared with omnivorous control diets (WMD −0.04 mg/L, 95% CI −0.23 to 0.15, p=0.683). All 12 subgroup analyses — by diet strictness, baseline CRP, duration, BMI, sex, age, and health status — were non-significant. GRADE certainty is moderate; no COI. The authors propose a time-lag hypothesis: the CRP benefit observed in long-term observational studies may not materialize within the weeks-to-months timescales that RCTs test. Actionable takeaway: CRP is not a reliable short-term biomarker of dietary progress for vegetarian diet switchers; dietitians seeking CRP reduction within weeks should prioritize weight loss, Mediterranean patterns, or UPF reduction instead.

Nutrition Research Brief06/13/2026, 08:17:06 PM

Ketone supplements improved heart pumping in heart failure — but this is not a case for keto diets

A 6-RCT meta-analysis in Heart (BMJ) by Liao et al. (University of Sydney, 2026) found that exogenous ketone supplementation raised left ventricular ejection fraction by 3.12 percentage points in heart failure patients overall, and by 4.25 points in the HFrEF subgroup. The evidence is entirely from manufactured ketone supplements, not ketogenic diets. The actionable takeaway is audience-segmented: heart failure patients have something to discuss with their cardiologist; dietitians should resist translating this to dietary keto recommendations; healthy adults have no dietary action today.